Membrane fusion in muscle development and repair

Seminars in Cell and Developmental Biology

Volumn 45, Issue , 2015, Pages 48-56

  Demonbreun, Alexis R ^a   Biersmith, Bridget H ^a   McNally, Elizabeth M ^a  

^a Program in Bioethics   (United States)

Author keywords

Development; Fusion; Membrane; Muscle; Myoblast; Repair

Indexed keywords

ANGIOGENESIS INHIBITOR; ANNEXIN; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR; CELL ADHESION MOLECULE; CELL PROTEIN; CELL SURFACE PROTEIN; GTPASE REGULATOR ASSOCIATED WITH FOCAL ADHESION KINASE 1; MEMBRANE PROTEIN; MUCOLIPIN 1; MYOMAKER; UNCLASSIFIED DRUG; SIGNAL PEPTIDE;

ACTIN FILAMENT; AMINO TERMINAL SEQUENCE; CELL ADHESION; CELL MIGRATION; DROSOPHILA; HUMAN; LOSS OF FUNCTION MUTATION; MEMBRANE FUSION; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MYOBLAST; MYOTUBE; NONHUMAN; REVIEW; TISSUE REPAIR; ANIMAL; CELL MEMBRANE; PHYSIOLOGY; SKELETAL MUSCLE; WOUND HEALING;

ANIMALS; CELL ADHESION; CELL MEMBRANE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE FUSION; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; WOUND HEALING;

EID: 84949267203     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.10.026     Document Type: Review

References (89)

1. Franzini-Armstrong C., Porter K.R. Sarcolemmal invaginations constituting the T system in fish muscle fibers. J. Cell Biol. 1964, 22:675-696.
2. Campbell K.P., Stull J.T. Skeletal muscle basement membrane-sarcolemma-cytoskeleton interaction minireview series. J. Biol. Chem. 2003, 278:12599-12600.
3. Yin H., Price F., Rudnicki M.A. Satellite cells and the muscle stem cell niche. Physiol. Rev. 2013, 93:23-67.
4. Cooper S.T., Head S.I. Membrane injury and repair in the muscular dystrophies. Neuroscientist 2014.
5. Abmayr S.M., Pavlath G.K. Myoblast fusion: lessons from flies and mice. Development 2012, 139:641-656.
6. Rochlin K., Yu S., Roy S., Baylies M.K. Myoblast fusion: when it takes more to make one. Dev. Biol. 2010, 341:66-83.
7. Biressi S., Rando T.A. Heterogeneity in the muscle satellite cell population. Semin. Cell Dev. Biol. 2010, 21:845-854.
8. Kim J.H., Jin P., Duan R., Chen E.H. Mechanisms of myoblast fusion during muscle development. Curr. Opin. Genet. Dev. 2015, 32:162-170.
9. Bothe I., Deng S., Baylies M. PI(4,5)P2 regulates myoblast fusion through Arp2/3 regulator localization at the fusion site. Development 2014, 141:2289-2301.
10. Kim J.H., Ren Y., Ng W.P., Li S., Son S., Kee Y.S., et al. Mechanical tension drives cell membrane fusion. Dev. Cell 2015, 32:561-573.
11. Simionescu A., Pavlath G.K. Molecular mechanisms of myoblast fusion across species. Adv. Exp. Med. Biol. 2011, 713:113-135.
12. San Miguel-Ruiz J.E., Letourneau P.C. The role of Arp2/3 in growth cone actin dynamics and guidance is substrate dependent. J. Neurosci. 2014, 34:5895-5908.
13. Shin N.Y., Choi H., Neff L., Wu Y., Saito H., Ferguson S.M., et al. Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts. J. Cell Biol. 2014, 207:73-89.
14. Kim S., Shilagardi K., Zhang S., Hong S.N., Sens K.L., Bo J., et al. A critical function for the actin cytoskeleton in targeted exocytosis of prefusion vesicles during myoblast fusion. Dev. Cell 2007, 12:571-586.
15. Deleu M., Crowet J.M., Nasir M.N., Lins L. Complementary biophysical tools to investigate lipid specificity in the interaction between bioactive molecules and the plasma membrane: a review. Biochim. Biophys. Acta 2014, 1838:3171-3190.
16. Jeong J., Conboy I.M. Phosphatidylserine directly and positively regulates fusion of myoblasts into myotubes. Biochem. Biophys. Res. Commun. 2011, 414:9-13.
17. Taulet N., Comunale F., Favard C., Charrasse S., Bodin S., Gauthier-Rouviere C. N-cadherin/p120 catenin association at cell-cell contacts occurs in cholesterol-rich membrane domains and is required for RhoA activation and myogenesis. J. Biol. Chem. 2009, 284:23137-23145.
18. Mukai A., Kurisaki T., Sato S.B., Kobayashi T., Kondoh G., Hashimoto N. Dynamic clustering and dispersion of lipid rafts contribute to fusion competence of myogenic cells. Exp. Cell Res. 2009, 315:3052-3063.
19. Strunkelnberg M., Bonengel B., Moda L.M., Hertenstein A., de Couet H.G., Ramos R.G., et al. rst and its paralogue kirre act redundantly during embryonic muscle development in Drosophila. Development 2001, 128:4229-4239.
20. Srinivas B.P., Woo J., Leong W.Y., Roy S. A conserved molecular pathway mediates myoblast fusion in insects and vertebrates. Nat. Genet. 2007, 39:781-786.
21. Dworak H.A., Charles M.A., Pellerano L.B., Sink H. Characterization of Drosophila hibris, a gene related to human nephrin. Development 2001, 128:4265-4276.
22. Shelton C., Kocherlakota K.S., Zhuang S., Abmayr S.M. The immunoglobulin superfamily member Hbs functions redundantly with Sns in interactions between founder and fusion-competent myoblasts. Development 2009, 136:1159-1168.
23. Sohn R.L., Huang P., Kawahara G., Mitchell M., Guyon J., Kalluri R., et al. A role for nephrin, a renal protein, in vertebrate skeletal muscle cell fusion. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9274-9279.
24. Moore C.A., Parkin C.A., Bidet Y., Ingham P.W. A role for the Myoblast city homologues Dock1 and Dock5 and the adaptor proteins Crk and Crk-like in zebrafish myoblast fusion. Development 2007, 134:3145-3153.
25. Lafuste P., Sonnet C., Chazaud B., Dreyfus P.A., Gherardi R.K., Wewer U.M., et al. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol. Biol. Cell 2005, 16:861-870.
26. Schwander M., Leu M., Stumm M., Dorchies O.M., Ruegg U.T., Schittny J., et al. Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev. Cell 2003, 4:673-685.
27. Dowling J.J., Gibbs E.M., Feldman E.L. Membrane traffic and muscle: lessons from human disease. Traffic 2008, 9:1035-1043.
28. Liu Z.C., Geisbrecht E.R. "Importin" signaling roles for import proteins: the function of Drosophila importin-7 (DIM-7) in muscle-tendon signaling. Cell Adh. Migr. 2012, 6:4-12.
29. Hollnagel A., Grund C., Franke W.W., Arnold H.H. The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration. Mol. Cell. Biol. 2002, 22:4760-4770.
30. Zeschnigk M., Kozian D., Kuch C., Schmoll M., Starzinski-Powitz A. Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J. Cell Sci. 1995, 108(Pt 9):2973-2981.
31. Laurin M., Cote J.F. Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev. 2014, 28:533-547.
32. Biersmith B., Wang Z.H., Geisbrecht E.R. Fine-tuning of the actin cytoskeleton and cell adhesion during drosophila development by the unconventional guanine nucleotide exchange factors myoblast city and sponge. Genetics 2015, 200(2):551-567.
33. Namekata K., Kimura A., Kawamura K., Harada C., Harada T. Dock GEFs and their therapeutic potential: neuroprotection and axon regeneration. Prog. Retin. Eye Res. 2014, 43:1-16.
34. Laurin M., Fradet N., Blangy A., Hall A., Vuori K., Cote J.F. The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15446-15451.
35. Achanzar W.E., Ward S. A nematode gene required for sperm vesicle fusion. J. Cell Sci. 1997, 110(Pt 9):1073-1081.
36. Bashir R., Britton S., Strachan T., Keers S., Vafiadaki E., Lako M., et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat. Genet. 1998, 20:37-42.
37. Liu J., Aoki M., Illa I., Wu C., Fardeau M., Angelini C., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 1998, 20:31-36.
38. Bansal D., Campbell K.P. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 2004, 14:206-213.
39. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172.
40. Davis D.B., Doherty K.R., Delmonte A.J., McNally E.M. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J. Biol. Chem. 2002, 277:22883-22888.
41. Lek A., Evesson F.J., Sutton R.B., North K.N., Cooper S.T. Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair. Traffic 2012, 13:185-194.
42. Davis D.B., Delmonte A.J., Ly C.T., McNally E.M. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum. Mol. Genet. 2000, 9:217-226.
43. Doherty K.R., Cave A., Davis D.B., Delmonte A.J., Posey A., Earley J.U., et al. Normal myoblast fusion requires myoferlin. Development 2005, 132:5565-5575.
44. Therrien C., Di Fulvio S., Pickles S., Sinnreich M. Characterization of lipid binding specificities of dysferlin C2 domains reveals novel interactions with phosphoinositides. Biochemistry 2009, 48:2377-2384.
45. Anderson L.V., Davison K., Moss J.A., Young C., Cullen M.J., Walsh J., et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 1999, 8:855-861.
46. Roche J.A., Ru L.W., O'Neill A.M., Resneck W.G., Lovering R.M., Bloch R.J. Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods. J. Histochem. Cytochem. 2011, 59:964-975.
47. Klinge L., Harris J., Sewry C., Charlton R., Anderson L., Laval S., et al. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle. Muscle Nerve 2010, 41:166-173.
48. 2+ signaling in the transverse tubule membrane. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:20831-20836.
49. Lek A., Evesson F.J., Lemckert F.A., Redpath G.M., Lueders A.K., Turnbull L., et al. Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair. J. Neurosci. 2013, 33:5085-5094.
50. Ho M., Post C.M., Donahue L.R., Lidov H.G., Bronson R.T., Goolsby H., et al. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum. Mol. Genet. 2004, 13:1999-2010.
51. Demonbreun A.R., Fahrenbach J.P., Deveaux K., Earley J.U., Pytel P., McNally E.M. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum. Mol. Genet. 2010, 20(4):779-789.
52. Demonbreun A.R., Rossi A.E., Alvarez M.G., Swanson K.E., Deveaux H.K., Earley J.U., et al. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. Am. J. Pathol. 2014, 184:248-259.
53. de Luna N., Gallardo E., Soriano M., Dominguez-Perles R., de la Torre C., Rojas-Garcia R., et al. Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro". J. Biol. Chem. 2006, 281:17092-17098.
54. Doherty K.R., Demonbreun A.R., Wallace G.Q., Cave A., Posey A.D., Heretis K., et al. The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J. Biol. Chem. 2008, 283:20252-20260.
55. Lostal W., Bartoli M., Roudaut C., Bourg N., Krahn M., Pryadkina M., et al. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy. PLoS One 2012, 7:e63803.
56. Grant B.D., Caplan S. Mechanisms of EHD/RME-1 protein function in endocytic transport. Traffic 2008, 9:2043-2052.
57. Posey A.D., Pytel P., Gardikiotes K., Demonbreun A.R., Rainey M., George M., et al. Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion. J. Biol. Chem. 2011, 286:7379-7388.
58. Marg A., Schoewel V., Timmel T., Schulze A., Shah C., Daumke O., et al. Sarcolemmal repair is a slow process and includes EHD2. Traffic 2012, 13:1286-1294.
59. Posey A.D., Swanson K.E., Alvarez M.G., Krishnan S., Earley J.U., Band H., et al. EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev. Biol. 2014, 387:179-190.
60. Lenhart K.C., Becherer A.L., Li J., Xiao X., McNally E.M., Mack C.P., et al. GRAF1 promotes ferlin-dependent myoblast fusion. Dev. Biol. 2014, 393:298-311.
61. Gudmundsson H., Curran J., Kashef F., Snyder J.S., Smith S.A., Vargas-Pinto P., et al. Differential regulation of EHD3 in human and mammalian heart failure. J. Mol. Cell. Cardiol. 2012, 52:1183-1190.
62. Blackwood R.A., Ernst J.D. Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem. J. 1990, 266:195-200.
63. Zaks W.J., Creutz C.E. Ca(2+)-dependent annexin self-association on membrane surfaces. Biochemistry 1991, 30:9607-9615.
64. Gunteski-Hamblin A.M., Song G., Walsh R.A., Frenzke M., Boivin G.P., Dorn G.W., et al. Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am. J. Physiol. 1996, 270:H1091-H1100.
65. Bizzarro V., Fontanella B., Franceschelli S., Pirozzi M., Christian H., Parente L., et al. Role of Annexin A1 in mouse myoblast cell differentiation. J. Cell. Physiol. 2010, 224:757-765.
66. Leikina E., Melikov K., Sanyal S., Verma S.K., Eun B., Gebert C., et al. Extracellular annexins and dynamin are important for sequential steps in myoblast fusion. J. Cell Biol. 2013, 200:109-123.
67. Babbin B.A., Laukoetter M.G., Nava P., Koch S., Lee W.Y., Capaldo C.T., et al. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J. Immunol. 2008, 181:5035-5044.
68. Babbin B.A., Parkos C.A., Mandell K.J., Winfree L.M., Laur O., Ivanov A.I., et al. Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am. J. Pathol. 2007, 170:951-966.
69. Lennon N.J., Kho A., Bacskai B.J., Perlmutter S.L., Hyman B.T., Brown R.H. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J. Biol. Chem. 2003, 278(50):50466-50473.
70. McNeil A.K., Rescher U., Gerke V., McNeil P.L. Requirement for annexin A1 in plasma membrane repair. J. Biol. Chem. 2006, 281:35202-35207.
71. Roostalu U., Strahle U. In vivo imaging of molecular interactions at damaged sarcolemma. Dev. Cell 2012, 22:515-529.
72. Swaggart K.A., Demonbreun A.R., Vo A.H., Swanson K.E., Kim E.Y., Fahrenbach J.P., et al. Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:6004-6009.
73. Cai C., Masumiya H., Weisleder N., Matsuda N., Nishi M., Hwang M., et al. MG53 nucleates assembly of cell membrane repair machinery. Nat. Cell Biol. 2009, 11:56-64.
74. Rong B., Zhao C., Liu H., Ming Z., Cai X., Gao W., et al. Elevated serum annexin A1 as potential diagnostic marker for lung cancer: a retrospective case-control study. Am. J. Transl. Res. 2014, 6:558-569.
75. Gurluler E., Guner O.S., Tumay L.V., Turkel Kucukmetin N., Hizli B., Zorluoglu A. Serum annexin A2 levels in patients with colon cancer in comparison to healthy controls and in relation to tumor pathology. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2014, 20:1801-1807.
76. Cagliani R., Magri F., Toscano A., Merlini L., Fortunato F., Lamperti C., et al. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. Hum. Mutat. 2005, 26:283.
77. Meroni G., Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. BioEssays 2005, 27:1147-1157.
78. Cai C., Weisleder N., Ko J.K., Komazaki S., Sunada Y., Nishi M., et al. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J. Biol. Chem. 2009, 284:15894-15902.
79. Weisleder N., Takizawa N., Lin P., Wang X., Cao C., Zhang Y., et al. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci. Transl. Med. 2012, 4(139):ra85.
80. Waddell L.B., Lemckert F.A., Zheng X.F., Tran J., Evesson F.J., Hawkes J.M., et al. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch. J. Neuropathol. Exp. Neurol. 2011, 70:302-313.
81. Doherty J.T., Lenhart K.C., Cameron M.V., Mack C.P., Conlon F.L., Taylor J.M. Skeletal muscle differentiation and fusion are regulated by the BAR-containing Rho-GTPase-activating protein (Rho-GAP), GRAF1. J. Biol. Chem. 2011, 286:25903-25921.
82. Simionescu-Bankston A., Leoni G., Wang Y., Pham P.P., Ramalingam A., DuHadaway J.B., et al. The N-BAR domain protein Bin3, regulates Rac1- and Cdc42-dependent processes in myogenesis. Dev. Biol. 2013, 382:160-171.
83. Millay D.P., O'Rourke J.R., Sutherland L.B., Bezprozvannaya S., Shelton J.M., Bassel-Duby R., et al. Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature 2013, 499:301-305.
84. Millay D.P., Sutherland L.B., Bassel-Duby R., Olson E.N. Myomaker is essential for muscle regeneration. Genes Dev. 2014, 28:1641-1646.
85. Park D., Tosello-Trampont A.C., Elliott M.R., Lu M., Haney L.B., Ma Z., et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007, 450:430-434.
86. Hochreiter-Hufford A.E., Lee C.S., Kinchen J.M., Sokolowski J.D., Arandjelovic S., Call J.A., et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature 2013, 497:263-267.
87. van den Eijnde S.M., van den Hoff M.J., Reutelingsperger C.P., van Heerde W.L., Henfling M.E., Vermeij-Keers C., et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 2001, 114:3631-3642.
88. Hamoud N., Tran V., Croteau L.P., Kania A., Cote J.F. G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:3745-3750.
89. Cheng X., Zhang X., Gao Q., Ali Samie M., Azar M., Tsang W.L., et al. The intracellular Ca(2)(+) channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nat. Med. 2014, 20:1187-1192.